The Nobel Prize in Physiology or Medicine for 2026 was awarded jointly to Karl Deisseroth of Stanford University, Peter Hegemann of Humboldt University of Berlin, and Georg Nagel of the University of Würzburg. The three researchers received the honor “for their discoveries concerning light-gated ion channels and optogenetics.” The prize, announced on Monday by the Nobel assembly at the Karolinska Institute in Stockholm, carries a monetary award of 12 million Swedish kronor, to be divided equally among the recipients.
The research originated from Hegemann’s investigation into how a green algae species navigates toward light. His work revealed that the organism’s eye spot contains a light-sensitive protein capable of converting light into electrical signals nearly instantaneously. Building on this foundation, Hegemann and Nagel identified proteins called channelrhodopsins and demonstrated their light-responsive properties using frog egg cells and subsequently mammalian kidney cells. The pair showed that exposure to blue light caused these proteins to permit charged particles to enter cells, generating electrical impulses.
Deisseroth advanced the field substantially by introducing channelrhodopsin genes into nerve cells of laboratory animals, enabling researchers to trigger electrical signals using light delivered through tiny optical fibers. Experiments in mouse brains revealed the ability to activate specific neural circuits and investigate their roles in memory formation and fear responses. The work established a foundation for understanding cause-and-effect relationships in neural function rather than merely observing anatomical correlations.
The practical applications of optogenetics have already demonstrated clinical promise. In a notable trial, researchers used the technique to partially restore vision to a patient with retinitis pigmentosa, a condition causing retinal degeneration. Channelrhodopsin genes were delivered to retinal cells via a harmless virus, and the patient subsequently used specially designed goggles to convert visual images into light pulses for retinal stimulation. Scientists anticipate the technology may offer new therapeutic avenues for neurological and psychiatric disorders, including dementia, epilepsy, and addiction, by enabling precise mapping of brain cell function and identification of cellular dysfunction in disease states.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI